Technology Law Source

Tag Archives: Innovation

S. 3187, “Food and Drug Administration Safety and Innovation Act” passes in Senate

Prior to adjourning for the Memorial Say recess, the Senate, on 05/24/2012, by a vote of 96-1, passed  S. 3187, the "Food and Drug Administration Safety and Innovation Act", " To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes", after previously adopting an amendment in the nature of a substitute-  an amendment in the nature of a substitute strips all of the language of a bill following the enacting clause and replaces it with new language – offered by Senator Tom Harkin (D-Iowa). Included as part of the language of the amendment was Title XI – Other Provisions, Subtitle C- Misc. Provisions, Section 1133, "Nanotechnology Regulatory Science Program":

SEC. 1133. NANOTECHNOLOGY REGULATORY SCIENCE PROGRAM.

    (a) In General- Chapter X (21 U.S.C. 391 et seq.) is amended by adding at the end the following:

`SEC. 1013. NANOTECHNOLOGY REGULATORY SCIENCE PROGRAM.

    `(a) In General- Not later than 180 days after the date of enactment of the Food and Drug Administration Safety and Innovation Act, the Secretary, in consultation as appropriate with the Secretary of Agriculture, shall establish within the Food and Drug Administration a Nanotechnology Regulatory Science Program (referred to in this section as the `program’) to enhance scientific knowledge regarding nanomaterials included or intended for inclusion in products regulated under this Act or other statutes administered by the Food and Drug Administration, to address

U.K. Providing Funding for Nanotech Innovations in Healthcare

Earlier this month, the U.K.’s Engineering and Physical Sciences Research Council (EPSRC) and the Technology Strategy Board (TSB) announced that they would be providing grants totalling over £6.5 million ($10,285,345.31) to

seven business-led projects that will focus on developing therapeutic agents and diagnostics where nanoscale technologies are at the heart of the innovation.

The aim of the investment is to help ensure that the UK can become an early competitive adopter of these novel technologies and rapidly meet the urgent and difficult challenges posed within the worldwide healthcare sector, by translating world-class early stage ideas from academia and commercialising them through building supply chains with innovative businesses.

The funding is conditional, subject to compliance and financial reviews by EPSRC and TSB. The U.K. views this funding as actively supporting growth in the British economy through healthcare technologies.

The companies involved in these projects are:

Critical Pharmaceuticals Ltd

Johnson Matthey plc

 Mologic Ltd

Nanomerics Ltd

OJ-Bio Ltd

Renishaw Diagnostics Ltd

Sharp Laboratories of Europe Ltd., a subsidiary of Sharp Corporation of Japan.

A list of the projects funded by the grants may be found here.

NorTech Announces Innovation Award Winners

NorTech just announced the winners of its 2007 Innovation Award at its Summit in Westlake, Ohio.  Crain’s Cleveland has the story here.  Among the winners was one local nanotechnology company, NanoMimetics, Inc., which according to Crain’s develops and commercializes nanocoatings for medical and industrial applications.  Congratulations to all! …

LexBlog